GemVax & KAEL Co Ltd
KOSDAQ:082270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tantia Constructions Ltd
NSE:TANTIACONS
|
IN |
|
BGI Genomics Co Ltd
SZSE:300676
|
CN |
|
B
|
BNP Paribas SA
XETRA:BNP
|
FR |
|
S
|
SBH Marine Holdings Bhd
KLSE:SBH
|
MY |
|
H
|
Hand Enterprise Solutions Co Ltd
SZSE:300170
|
CN |
|
VanJee Technology Co Ltd
SZSE:300552
|
CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
CN |
GemVax & KAEL Co Ltd
Total Equity
GemVax & KAEL Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
Total Equity
₩50.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
1%
|
|
|
Hanmi Semiconductor Co Ltd
KRX:042700
|
Total Equity
₩690.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
14%
|
|
|
E
|
EO Technics Co Ltd
KOSDAQ:039030
|
Total Equity
₩687.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
W
|
Wonik IPS Co Ltd
KOSDAQ:240810
|
Total Equity
₩970B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
H
|
HPSP Co Ltd
KOSDAQ:403870
|
Total Equity
₩277.9B
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
ISC Co Ltd
KOSDAQ:095340
|
Total Equity
₩536.6B
|
CAGR 3-Years
26%
|
CAGR 5-Years
25%
|
CAGR 10-Years
14%
|
|
GemVax & KAEL Co Ltd
Glance View
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.
See Also
What is GemVax & KAEL Co Ltd's Total Equity?
Total Equity
50.3B
KRW
Based on the financial report for Dec 31, 2025, GemVax & KAEL Co Ltd's Total Equity amounts to 50.3B KRW.
What is GemVax & KAEL Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
1%
Over the last year, the Total Equity growth was 73%. The average annual Total Equity growth rates for GemVax & KAEL Co Ltd have been -28% over the past three years , -18% over the past five years , and 1% over the past ten years .
